Cargando…
Use of Dexmedetomidine and Opioids in Hospitalized Preterm Infants
IMPORTANCE: Dexmedetomidine, an α(2)-adrenergic agonist, is not approved by the Food and Drug Administration for use in premature infants. However, the off-label use of dexmedetomidine in premature infants has increased 50-fold in the past decade. Currently, there are no large studies characterizing...
Autores principales: | Curtis, Samantha, Kilpatrick, Ryan, Billimoria, Zeenia C., Zimmerman, Kanecia, Tolia, Veeral, Clark, Reese, Greenberg, Rachel G., Puia-Dumitrescu, Mihai |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Medical Association
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10625033/ https://www.ncbi.nlm.nih.gov/pubmed/37921767 http://dx.doi.org/10.1001/jamanetworkopen.2023.41033 |
Ejemplares similares
-
Association of Antibiotic Duration and Outcomes among NICU Infants with Invasive Staphylococcus aureus Infections
por: Bukhari, Areej, et al.
Publicado: (2021) -
The Prevalence and Clinical Significance of Congenital Anomalies of the Kidney and Urinary Tract in Preterm Infants
por: Hays, Thomas, et al.
Publicado: (2022) -
Assessment of 2-Year Neurodevelopmental Outcomes in Extremely Preterm Infants Receiving Opioids and Benzodiazepines
por: Puia-Dumitrescu, Mihai, et al.
Publicado: (2021) -
Deaths in a Modern Cohort of Extremely Preterm Infants From the Preterm Erythropoietin Neuroprotection Trial
por: Juul, Sandra E., et al.
Publicado: (2022) -
Case report of congenital methemoglobinemia: an uncommon cause of neonatal cyanosis
por: Lyle, Allison N. J., et al.
Publicado: (2022)